Optimas Capital’s Boston Scientific BSX Stock Holding History

Optimas Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,526	Closed	-$2.9M	–	36
2023 Q2	$2.9M	Buy	+53,526	New	+$2.8M	3.35%	13

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Optimas Capital's BSX Position: Q3 2023 in Review

Optimas Capital sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 53,526 shares — an estimated $2.9M sold.

Optimas Capital first reported a position in BSX in Q2 2023 and held it in 1 quarter. The position peaked at $2.9M in Q2 2023. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

Optimas Capital reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
Optimas Capital sold 53,526 Boston Scientific shares in Q3 2023, an estimated $2.9M.
Optimas Capital first reported a position in Boston Scientific in Q2 2023 and held it in 1 quarter.
Optimas Capital's Boston Scientific position peaked at $2.9M in Q2 2023.
1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Optimas Capital's 13F filing for Q3 2023, filed 31 Oct 2023.